AKTX
Akari Therapeutics
AKTX
AKTX
12 hedge funds and large institutions have $3.35M invested in Akari Therapeutics in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
Renaissance Technologies
New York
|
-$61.7K |
2 |
HighTower Advisors
Chicago,
Illinois
|
-$30K |
3 |
TSS
Two Sigma Securities
New York
|
-$22K |
4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$18K |
5 |
Morgan Stanley
New York
|
-$1.08K |